Published in

American Heart Association, Arteriosclerosis, Thrombosis, and Vascular Biology, 12(34), p. 2579-2585, 2014

DOI: 10.1161/atvbaha.114.304492

Links

Tools

Export citation

Search in Google Scholar

Protein Kinase C δ Deficiency Enhances Megakaryopoiesis and Recovery From Thrombocytopenia

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Objective— We previously determined that protein kinase C δ (PKCδ) regulates platelet function. However, the function of PKCδ in megakaryopoiesis is unknown. Approach and Results— Using PKCδ -/- and wild-type littermate mice, we found that deficiency of PKCδ caused an increase in white blood cells and platelet counts, as well as in bone marrow and splenic megakaryocytes ( P <0.05). Additionally, the megakaryocyte number and DNA content were enhanced in PKCδ -/- mouse bone marrow after culturing with exogenous thrombopoietin compared with wild-type ( P <0.05). Importantly, thrombopoietin-induced signaling was also altered with PKCδ deletion because both extracellular signal-regulated kinase and Akt308 phosphorylation were heightened in PKCδ -/- megakaryocytes compared with wild-type. Finally, PKCδ -/- mice recovered faster and had a heightened rebound thrombocytosis after thrombocytopenic challenge. Conclusions— These data suggest that PKCδ is an important megakaryopoietic protein, which regulates signaling induced by thrombopoietin and represents a potential therapeutic target.